Top News

American Apparel Got Indication of Interest for $1.30-$1.40 per Share

Australia, N.Z. Stocks: Austal, ResMed, Fisher & Paykel Health

Australia’s S&P/ASX 200 Index fell 0.6 percent to 4,603.2 as of 10:51 a.m. in Sydney. New Zealand’s NZX 50 Index (NZSE50FG) rose 0.5 percent to 3,578.08 in Wellington.

The following were among the most active shares in the market today. Stock symbols are in parentheses after company names.

Gold producers: Gold futures for June delivery gained 0.5 percent to settle at $1,523.30 an ounce on the Comex in New York, the highest closing price for a most-active contract since May 3.

Newcrest Mining Ltd. (NCM) , Australia’s biggest gold producer, advanced 0.3 percent to A$38.15. Alacer Gold Corp. (AQG AU) surged 8.2 percent to A$9.22.

Austal Ltd. (ASB) plunged 12 percent to A$2.55 after the shipbuilder released a full-year profit forecast.

Campbell Brothers Ltd. (CPB) declined 0.7 percent to A$44.63. The manufacturer of cleaning agents was cut to “neutral” from “overweight” at JPMorgan Chase & Co. and to “hold” from “buy” at Royal Bank of Scotland Group Plc. Ltd. (CRZ) , Australia’s most popular automotive website, rose 1.1 percent to A$4.74 after announcing a share buyback.

ConnectEast Group (CEU) dropped 1 percent to 48 Australian cents. The operator of the EastLink toll road in Australia’s Victoria state was downgraded to “neutral” at Macquarie Research. The stock was previously rated “outperform,” according to data compiled by Bloomberg.

Elders Ltd. (ELD) declined 2.2 percent to 45 Australian cents. The Australian supplier of rural services was downgraded to “underperform” from “speculative buy” with a 12-month price target at A$0.40 a share by John Welsh, an analyst at BBY Limited.

Pharmaxis Ltd. (PXS) tumbled 72 percent to 83 Australian cents. The company, which develops products for chronic respiratory and autoimmune diseases, said the Committee for Medicinal Products for Human Use indicated it would vote against the approval of Bronchitol.

ResMed Inc. (RMD) gained 1.7 percent to A$2.99 after the maker of machines to overcome night-time breathing disorders had its stock rating raised to “buy” from “neutral” at Merrill Lynch.

Treasury Wine Estates Ltd. (TWE AU) advanced 1.6 percent to A$3.26 after the wine distributor was rated “buy” in new coverage at Merrill Lynch.

New Zealand:

Fisher & Paykel Healthcare Corp. (FPH NZ) fell 2.9 percent to NZ$3.02, a New Zealand maker of breathing masks and hospital equipment, reported a 27 percent decline in full-year profit on a stronger currency and one-time tax expenses.

To contact the reporter on this story: Shani Raja in Sydney at

To contact the editors responsible for this story: Nick Gentle at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.